Over the past couple of years, not one but two malaria vaccines have launched onto the market: the RTS,S made by pharmaceutical company GSK and the R21/Matrix-M developed by the University of Oxford ...

Our product has been evaluated using the Consumer Product Safety Commission's protocol and standards. The test results ...

The global digital PCR market, initially valued at $678.1 million in 2023, is poised for substantial growth, projected to surge to $3.35 billion by 2034, marking a remarkable compound annual growth ...

The option to use post-consumer recycled (PCR) materials further reinforces ONE’s commitment ... The light-colored design ...

Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that key opinion leader (“ KOL ”) collaborators are presenting results ...

Co-Diagnostics ( (CODX) ) has released its Q3 earnings. Here is a breakdown of the information Co-Diagnostics presented to its investors.

The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, and treatment. Unlike pharmaceuticals, medical devices work through ...

Aljaz: Icons are the same as legends. Icons are timeless and their impact stands the test of time. Talk us through the icon you are channelling on Icons Week? Tasha: It’s actually a very ...

The illness can be tough to identify and expensive to test for, and it can linger for several weeks, making it a frustrating sickness for families. Plus, treatment isn't necessarily one-size-fits-all.

Judging the true scale of the outbreak is a challenge because PCR tests are in short supply and are only available at a few private hospitals. They also cost about 8,000 rupees (£22), putting ...